Comment on

• How to manage a Barrett's esophagus patient with low-grade dysplasia.

  Wani S, Mathur S, Sharma P. Wani S, et al. Clin Gastroenterol Hepatol. 2009 Jan;7(1):27-32. doi: 10.1016/j.cgh.2008.08.014. Epub 2008 Aug 16. Clin Gastroenterol Hepatol. 2009. PMID: 18986846 Review. No abstract available.
• Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.

  Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Sikkema M, et al. Clin Gastroenterol Hepatol. 2010 Mar;8(3):235-44; quiz e32. doi: 10.1016/j.cgh.2009.10.010. Epub 2009 Oct 20. Clin Gastroenterol Hepatol. 2010. PMID: 19850156
• Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.

  Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Wani S, et al. Clin Gastroenterol Hepatol. 2011 Mar;9(3):220-7; quiz e26. doi: 10.1016/j.cgh.2010.11.008. Epub 2010 Nov 27. Clin Gastroenterol Hepatol. 2011. PMID: 21115133
• Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus.

  Schouten LJ, Steevens J, Huysentruyt CJ, Coffeng CE, Keulemans YC, van Leeuwen FE, Driessen AL, van den Brandt PA. Schouten LJ, et al. Clin Gastroenterol Hepatol. 2011 Sep;9(9):754-61. doi: 10.1016/j.cgh.2011.04.008. Epub 2011 Apr 15. Clin Gastroenterol Hepatol. 2011. PMID: 21570484